Fig. 8
Migration assay of HUVECs through a transwell chamber over 6 h (1) and the average number of cells migrating (2). (A) HUVECs treated with REDV-TAT-NLS-H0/pZNF580 complexes, (B) HUVECs treated with REDV-TAT-NLS-H4/pZNF580 complexes, (C) HUVECs treated with REDV-TAT-NLS-H8/pZNF580 complexes, (D) HUVECs treated with REDV-TAT-NLS-H12/pZNF580 complexes, (E) ECs treated with pZNF580 as a control group (mean ± SD, n = 3, *P < 0.05 vs. control group). #P < 0.05 vs. group A